XEUM:LSE:LSE-db x-trackers MSCI Europe Mid Cap UCITS DR 1C (GBX)

ETF | Others |

Last Closing

USD 13786

Change

+74.00 (+0.54)%

Market Cap

N/A

Volume

2.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 544.83B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 544.83B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 209.75B
0QZ3:LSE Qualcomm Inc.

N/A

USD 202.26B
0R24:LSE Intel Corp.

N/A

USD 196.14B

ETFs Containing XEUM:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.14% 52% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.14% 51% F 54% F
Trailing 12 Months  
Capital Gain 12.49% 60% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.49% 58% F 60% D-
Trailing 5 Years  
Capital Gain 51.33% 68% D+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 51.33% 66% D+ 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 10.65% 71% C- 73% C
Dividend Return 10.65% 70% C- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.96% 53% F 69% C-
Risk Adjusted Return 82.15% 88% B+ 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike